Results 211 to 220 of about 127,348 (379)

Tubulointerstitial nephritis and uveitis syndrome in children: What to keep an eye on

Acta Ophthalmologica, EarlyView.
Abstract Purpose The purpose of this study was to determine the disease course in patients with tubulointerstitial nephritis and uveitis (TINU) syndrome, focusing on long‐term outcome and the incidence of complications such as chronic kidney disease (CKD).
Jytte Hendrikse, Anne Sina Paula Simon, Viera Kalinina Ayuso, Joke Helena de Boer, Gerrit van den Berg   +4 more
wiley   +1 more source

Anti-Eukaryotic Initiation Factor 2B-Positive Systemic Sclerosis-Associated Interstitial Lung Disease With Progressive Fibrosis: A Case Report. [PDF]

Respirol Case Rep
Ikeda H, Tachikawa R, Sasada T, Sumitomo S.   +3 more
europepmc   +1 more source

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis–Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

Arthritis & Rheumatology, 2017
E. Volkmann, D. Tashkin, Ning Li, Michael D. Roth, D. Khanna, A. Hoffmann-Vold, G. Kim, J. Goldin, P. Clements, D. Furst, R. Elashoff   +10 more
semanticscholar   +1 more source

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802 [PDF]

, 2014
Javier Bolaños‐Meade, Brent R. Logan, Amin M. Alousi, Joseph H. Antin, Kate Barowski, Shelly L. Carter, Steven C. Goldstein, Elizabeth O. Hexner, Mary M. Horowitz, Stephanie J. Lee, John E. Levine, Margaret L. MacMillan, Paul J. Martin, Adam Mendizabal, Ryotaro Nakamura, Marcelo C. Pasquini, Daniel J. Weisdorf, Peter Westervelt, Vincent T. Ho   +18 more
openalex   +1 more source

The treatment based on calcineurin inhibitors and their conversion to sirolimus alter the morphology in the rat testis. [PDF]

Sci Rep
Grabowska M, Michałek K, Kędzierska-Kapuza K, Gill K, Piasecka M.   +4 more
europepmc   +1 more source

Interstitial lung disease treated with mycophenolate mofetil [PDF]

, 2013
Megan Cully
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Can mycophenolate mofetil be an effective option in the treatment of vascular Behçet's Syndrome. [PDF]

Sarcoidosis Vasc Diffuse Lung Dis
Uslu E, Göveç Giynaş N, Karaman Ongun Z, Sezer S, Yayla ME, Turgay TM, Ateş A.   +6 more
europepmc   +1 more source

Improved survival after acute graft-versus-host disease diagnosis in the modern era [PDF]

, 2017
et al.,, Hayashi, Robert J, Vig, Ravi
core   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source